Talent Pool

Contributed by:

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Pharmaceutical POOL

Alex Gorsky
Sheri McCoy
Johnson & Johnson Shifts Executives
Global healthcare company Johnson & Johnson has appointed Alex Gorsky worldwide chairman, surgical care group, with responsibility for the surgical franchises Ethicon, Ethicon Endo-Surgery, and DePuy, as well as J&J’s medical devices and diagnostics organizations in the Latin America, Europe/Middle East/Africa and Asia Pacific regions. Mr. Gorsky was previously company group chairman and worldwide franchise chairman, Ethicon. In his new role, Mr. Gorsky replaces Sheri McCoy, who has been named worldwide chairman, pharmaceuticals group. Ms. McCoy succeeds Christine Poon, who is retiring from J&J in March 2009. Biotechnology POOL Daniel Junius ImmunoGen President Assumes CEO Role Daniel Junius has assumed the role of president and CEO of ImmunoGen, succeeding Mitchel Sayare, Ph.D., who continues as chairman of the biotechnology firm. Mr. Junius joined ImmunoGen in 2005 and most recently served as president and chief operating officer. He received a master’s in management from Northwestern University’s Kellogg School of Management. ImmunoGen develops targeted anticancer therapeutics using its expertise in cancer biology, monoclonal antibodies, and the creation and attachment of potent cell-killing agents. Biopharmaceutical POOL Gustav Christensen Dyax Promotes Business Chief to President, CEO Dyax, a biopharmaceutical company with an emphasis on oncology and inflammatory therapeutics, has promoted Gustav Christensen to succeed cofounder Henry Blair as president and CEO. Mr. Blair remains chairman of Dyax. Mr. Christensen joined Dyax in 2007 as executive VP and chief business officer. He received an M.S. in economics from the University of Aarhus in Denmark and an MBA from Harvard Business School. Dr. Dennis Kim Orexigen Names Head of Obesity Development Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity and other related disorders, has appointed Dennis Kim, M.D., senior VP and head of obesity and metabolic disorders. Dr. Kim leads the clinical development activities for the company’s obesity franchise. Dr. Kim most recently was chief medical officer and VP of medical affairs for EnteroMedics. He holds an MBA from the Rady School of Management at the University of California, San Diego, and an M.D. from the Chicago Medical School of Rosalind Franklin University of Medicine and Science. Dr. Todd Lorenz Former J&J Executive Joins Catalyst as Chief Medical Officer Catalyst Biosciences, a biopharmaceutical company focused on the discovery and development of engineered proteases known as Alterase therapeutics, has appointed Todd Lorenz, M.D., chief medical officer. Dr. Lorenz was most recently VP and associate therapeutic head for cardiovascular development at Johnson & Johnson. He received an M.D. from Case Western Reserve University School of Medicine and completed a fellowship in endocrinology and metabolism at the University of California, San Francisco. Dr. Craig Rosen PhaseBio Selects Executive Chairman Craig Rosen, Ph.D., has joined Phase Bioscience (PhaseBio) as executive chairman. Dr. Rosen most recently served as senior VP and chief scientific officer at Teva Biopharmaceuticals USA and remains a consultant for that company. PhaseBio is a development-stage, privately held protein engineering company. Specialty POOL Dr. Richard Chin Former Oxigene CEO Picked to Lead OneWorld Health The Institute for OneWorld Health, a nonprofit pharmaceutical company that develops drugs for people with neglected infectious diseases in the developing world, has named Richard Chin, M.D., to succeed OneWorld cofounder Ahvie Herskowitz, M.D., as CEO. Dr. Chin was most recently president and CEO of Oxigene. He graduated magna cum laude with a B.A. in biology from Harvard University and received an M.D. from Harvard Medical School. Dr. Chin also earned a master’s degree and a B.A. in law with honors from Oxford University. Dr. Richard (Rick) Fuller Oriel Taps Industry Veteran as CEO Oriel Therapeutics, a specialty pharmaceutical company developing and commercializing products to improve respiratory care, has named Richard (Rick) Fuller, M.D., CEO. Dr. Fuller has 30 years of experience in healthcare R&D, most recently as executive VP of research and development for Aerovance. He received an M.D. from St. George’s, University of London, is a fellow of the Royal College of Physicians, and is clinically accredited in internal medicine and clinical pharmacology. Dr. Eric Lang New Research VP at Javelin Javelin Pharmaceuticals, a developer of novel products for pain management, has appointed Eric Lang, M.D., VP of clinical research. Dr. Lang was most recently global head of clinical research and development for analgesia for Novartis’ consumer health division. He received a medical degree at Ben Gurion University of the Negev. Discovery POOL Adelene Perkins Infinity Pharmaceuticals Promotes Chief Business Officer to President Infinity Pharmaceuticals, which discovers and develops cancer drugs, has promoted Adelene Perkins to president and chief business officer from executive VP and chief business officer. In this new role, Ms. Perkins continues to have responsibility for all of Infinity’s business functions. Ms. Perkins received a B.S. in chemical engineering from Villanova University and an MBA from Harvard Business School. Emerging POOL Dr. D. Euan MacIntyre Merck Research Veteran Joins Arete Therapeutics Arete Therapeutics, a privately held biopharmaceutical company developing first-in-class soluble epoxide hydrolase inhibitors, has named D. Euan MacIntyre, Ph.D., to the new position of senior VP, drug discovery. Dr. MacIntyre joins Arete after more than 22 years with Merck Research Laboratories, most recently serving as VP of pharmacology. Dr. MacIntyre is an alumnus of the University of Glasgow and holds a Ph.D. in pharmacology and experimental pathology from the University of Cambridge. He also served as a postdoctoral fellow at the University of Cambridge and Harvard Medical School. Agency POOL Marilyn Aquino Nick Casale Vincenzo Furia Sean Kinney Aaron Nietfeld Andrea O’Brien Michelle Schmidt Carbon Announces Promotions, Additions Carbon, a CommonHealth advertising and promotion agency created to serve the marketing needs of emerging pharma and biotech companies and specialty brands, has announced several additions and promotions. Marilyn Aquino has been promoted to account supervisor from senior account executive. Ms. Aquino has been with Carbon for almost three years. Nick Casale has joined Carbon from Noesis, another CommonHealth agency, as VP, group copy supervisor. Mr. Casale has worked within the CommonHealth network for three years. Vincenzo Furia has been named an account supervisor. Mr. Furia was previously a senior account executive at Creotex Communications. Sean Kinney has been appointed senior art director. Mr. Kinney most recently served in the role as art director for Sony BMG Music Entertainment. Aaron Nietfeld joins Carbon as a senior account executive. Mr. Nietfeld was previously an account executive at Torre Lazur McCann. Andrea O’Brien has been appointed an account supervisor, with responsibility for developing strategy and overseeing her clients’ projects from start to finish. Ms. O’Brien was most recently an account supervisor with Integrated Communications. Michelle Schmidt joins Carbon as a senior account executive. He held the same position at Sudler & Hennessey. Tracy Bender Megan Benjamin Denise Gianotti Tina Simitz Noesis Promotes Staff Noesis, a CommonHealth agency, has announced a number of promotions. Tracy Bender has been promoted to VP, associate creative director, from group copy supervisor. Megan Benjamin has been promoted to senior account executive from account executive. Denise Gianotti has been elevated to VP, director of operations, from director of operations. Tina Simitz has been promoted to VP, account group supervisor, from VP, account supervisor. Joann Flynn Stephanie Vieira Vox Medica Adds Two Client Solutions VPs Independent healthcare communications company Vox Medica has added two experienced industry executives to its client solutions team. Joann Flynn has joined Vox as VP, client solutions director, education and adult learning. Ms. Flynn most recently was strategic accounts director for Total Learning Concepts, a division of Publicis Selling Solutions Group. Stephanie Vieira brings 10 years of experience in strategic healthcare public relations and advocacy development to Vox Medica as VP, client solutions director, brand recognition. Ms. Vieira previously was a VP at Manning Selvage & Lee’s healthcare division. John Kearney Andrea Mills Dolores Palumbo Staff Moves at Ferguson Ferguson, the founding professional advertising and promotional agency of CommonHealth, has promoted John Kearney to director of editorial services from senior editor. Mr. Kearney has been with the agency since 2006. The agency also made two new hires to the staff. Joining Ferguson is Andrea Mills as an account executive assigned to multiple brands. Ms. Mills was most recently with Bristol-Myers Squibb. Dolores Palumbo has been named senior editor at Ferguson. She previously served as an editor for Torre Lazur McCann. Lisa Layher Topin Expands Client Services Team Full-service healthcare marketing communications agency Topin & Associates has hired Lisa Layher as account supervisor. Before joining Topin, Ms. Layher spent eight years as a senior account supervisor at Remedy. Joseph Mastracchio Veteran Agency Executive Returns to CommonHealth Healthcare communications network CommonHealth, a WPP company, welcomes back Joseph Mastracchio, who has rejoined the organization as executive VP, director of business integration, following a nine-year absence. In his new post, Mr. Mastracchio is responsible for leading new business efforts across the entire CommonHealth group, with particular focus on the medical education, managed markets, interactive, and research consultancy units. Mr. Mastracchio has almost 40 years of industry experience, 13 of which were spent running HLS, CommonHealth’s founding medical education unit. Most recently, Mr. Mastracchio served as managing director, strategic initiatives, at Beacon Healthcare Communications. Margaret Udell HC&B Adds to Interactive Division Independent healthcare agency HC&B Healthcare Communications has named Margaret Udell senior interactive producer in its interactive division, HC&B Digital. Ms. Udell previously spent five years as a freelance marketing consultant, developing Websites and managing direct marketing projects for clients such as AT&T, Circuit City, and Hyatt. Consulting POOL Michael Weiss Kinetix Group Appoints Sales VP The Kinetix Group, a New York-based healthcare consulting firm, has named Michael Weiss executive VP, sales and marketing. Mr. Weiss brings to Kinetix more than 25 years of experience in the healthcare industry, most recently as VP, sales, for /alert Marketing, a division of Jobson Publishing Group. CRO POOL Dr. Christophe Berthoux Charles River Appoints Executive to Lead Global Sales and Marketing Realignment Charles River Laboratories International has promoted Christophe Berthoux, D.V.M., to executive VP, global sales and marketing and chief commercial officer. In this newly created role, Dr. Berthoux is leading the global realignment of the drug-development company’s sales and marketing organization to further enhance its interface with its customers. Dr. Jerome Wilson New Medical Director Takes Office at PRA Privately held PRA International has named Jerome Wilson, Ph.D., senior medical director of late phase services. As PRA’s lead epidemiologist, Dr. Wilson is responsible for providing consulting services and developing postmarketing strategies for PRA clients. In addition to more than 15 years of scientific management experience in the pharmaceutical industry, Dr. Wilson served as senior interdisciplinary scientist and team leader for anthrax therapeutics at the U.S. Department of Health and Human Services. He earned an A.B. cum laude from Dillard University, an A.M. from Harvard Medical School, and a Ph.D. from the Gillings School of Global Public Health at the University of North Carolina. Medical-Education POOL Todd Weinstein L&M Healthcare Communications Expands Executive Staff The independent, full-service medical education company L&M Healthcare Communications has hired Todd Weinstein as VP, business development. Mr. Weinstein previously served as manager of publication sales at McMahon Publishing. Service POOL Partha Anbil Robert Becker Wolters Kluwer Health Announces Leadership Changes Partha Anbil has joined Wolters Kluwer Health, a Wolters Kluwer business, as practice leader, pharma solutions. Mr. Anbil has more than two decades of management consulting and organizational experience, including principal roles at IMS Health, BearingPoint, PricewaterhouseCoopers, and Deloitte Consulting. Mr. Anbil received an M.A. in economics and econometrics and an M.S. in corporate finance, both from the University of Toledo, and an MBA in corporate strategy and business development from the MIT Sloan School of Management. He also holds a master’s in international business (M.I.B.) from the Indian Institute of Foreign Trade. Wolters Kluwer also has named Robert Becker president and CEO of Wolters Kluwer Health. Mr. Becker was previously CEO of Wolters Kluwer Law & Business. He has a B.S. in accounting and finance from Marquette University and an MBA from the University of Connecticut. David McGuire Karen Walton-Bowen Additions at Abt Associates, Abt Bio-Pharma Consulting firm Abt Associates has appointed David McGuire to lead its international health division focused on commercial alliances and health services delivery. Mr. McGuire was previously with the Academy for Educational Development (AED), where he served as VP and director of the Center for Private Sector Health Initiatives, as well as NetMark program director. He received a B.A. from the University of Vermont and has completed coursework at the Institut Européen des Hautes Etudes Internationales. In other moves, Karen Walton-Bowen has joined Abt Associates subsidiary Abt Bio-Pharma Solutions (ABS) as senior director, biometrics. ABS provides integrated, strategic research and commercialization services to the pharmaceutical, biotechnology, medical-device, and diagnostics industries. Ms. Walton-Bowen was most recently senior director of clinical operations, biostatistical analysis and reporting, at Critical Therapeutics. She received a B.S. with honors in mathematics and computing from London South Bank University and an M.Sc. in medical statistics from the University of London. Dr. Josh Rossol Ziment Promotes Chief Methodologist Ziment, a healthcare and pharmaceutical market research consultancy, has promoted Josh Rossol, Ph.D., to chief methodologist from senior methodologist. In this new role, Dr. Rossol is responsible for leading product development and working with clients to bring appropriate, creative techniques to bear against difficult strategic issues. He has been with Ziment since 2003. Ziment is part of the Ziment Group, the global healthcare research brand for the Kantar Group, a WPP company. Technology POOL Peter Benton Chris Connor PDS Strengthens Leadership Phoenix Data Systems (PDS), the global clinical data services subsidiary of Bio-Imaging Technologies, has appointed Peter Benton president. Mr. Benton succeeds Dr. William Claypool, who has left PDS to start a pharmaceutical development consulting company, Pennmark Associates. Mr. Benton was most recently chief operating officer of an e-clinical technology services company. He earned a B.S. in mechanical engineering from Northeastern University and an MBA from The Wharton School of the University of Pennsylvania. PDS also has named Chris Connor to the newly created position of director of product development, with responsibility for guiding the software development roadmap for PDS’ Express suite of e-clinical technology products. Mr. Connor was previously senior research analyst at Health Industry Insights, an IDC company. F Send your personnel announcements to feedback@pharmavoice.com. See Digital EDITION for Bonus Content www.pharmavoice.com Pharma POOL Dr. Mace Rothenberg Pfizer Appoints Oncology Development Head Mace Rothenberg, M.D., has joined global pharmaceutical company Pfizer as senior VP, clinical development and medical affairs for its oncology business unit. Dr. Rothenberg’s responsibilities include overseeing clinical research and development activities and postmarketing evaluation and monitoring for all oncology products, as well as coordinating evaluation of anticancer compounds that emerge from Pfizer’s new biotechnology and bioinnovation center. Dr. Rothenberg has been active in clinical-translational research in oncology for more than 20 years, and most recently was professor of medicine at the Vanderbilt University Medical Center and Ingram professor of cancer research at the Vanderbilt-Ingram Cancer Center. He received a B.A. magna cum laude from the University of Pennsylvania and an M.D. from the New York University School of Medicine. Biotechnology POOL Frederic Chereau Pervasis Appoints CEO Pervasis Therapeutics, a biotechnology company pioneering biologically active therapies and devices to treat serious illnesses, has named Frederic Chereau president and CEO. Mr. Chereau was previously the VP and general manager of Genzyme Cardiovascular, a business unit of Genzyme Corp. Mr. Chereau holds an undergraduate degree in physics from Paris University, completed graduate studies at the La Rochelle Business School, and received an MBA from Insead. Dr. David DeMagistris Cerulean Strengthens Leadership Team David DeMagistris, Ph.D., has joined Cerulean Pharma as senior VP, pharmaceutical sciences. Dr. DeMagistris previously led strategic technology at GlaxoSmithKline. Cerulean, formerly known as Tempo Pharmaceuticals, is a biopharmaceutical company focused on developing novel nanoparticle-based drugs. Dr. Edward Geehr Abraxis Names Operations VP Global biotechnology company Abraxis BioScience has appointed Edward Geehr, M.D., executive VP of operations. In this newly created position, Dr. Geehr is responsible for the commercial, manufacturing, and marketing operations of Abraxis. Most recently, Dr. Geehr was president of Allez Spine. He received a B.A. from Yale University and an M.D. from Duke University. Abraxis is focused on next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. Dr. Bryan Leigh New Medical Chief at Tracon Pharmaceuticals Bryan Leigh, M.D., has joined Tracon Pharmaceuticals as chief medical officer from the same position at Paramount Biosciences. Tracon is a biopharmaceutical company developing targeted therapies for cancer and eye diseases. Dr. Leigh holds a B.S. in biological sciences with a focus on genetics from University of California, Irvine, and an M.D. from the University of California, San Francisco School of Medicine. Dr. Barry Polisky MDRNA Hires Former Merck VP as Chief Scientific Officer Barry Polisky, Ph.D., has joined MDRNA as chief scientific officer. MDRNA is a biotechnology company focused on developing therapeutic products based on RNA interference (RNAi). Dr. Polisky previously served as research VP for Merck. He received a Ph.D. in molecular biology from the University of Colorado. Specialty POOL Josh Franklin New Marketing VP at Cornerstone Cornerstone Therapeutics, a specialty company focused on medications for respiratory disorders, has appointed Josh Franklin VP, marketing. Mr. Franklin previously held the same position at Ther-Rx, a subsidiary of KV Pharmaceutical. Mr. Franklin received a B.S. in business administration from Methodist University and M.H.A. and MBA degrees from The Ohio State University. Dr. Theron (Ted) Odlaug CyDex President Assumes Chief Executive Role CyDex Pharmaceuticals, a specialty pharmaceutical company developing products that use its Captisol drug delivery technology, has named President Theron (Ted) Odlaug, Ph.D., to the additional role of CEO. Dr. Odlaug succeeds retiring CEO John Siebert, who also has stepped down as chairman of CyDex’s board. The board has elected director James Gale as its new chairman. Mr. Siebert remains as a consultant to aid CyDex in the transition. Dr. Odlaug joined CyDex as president and chief operating officer in May 2008. He holds a bachelor’s and a master’s degree from the University of Missouri at Kansas City and a Ph.D. in public health from the University of Minnesota. Association POOL George Rathbun CRIX Selects Pfizer Director as Technology Chief George Rathbun, a director in Pfizer’s development and medical informatics organization, has joined Clinical Research Information eXchange (CRIX) International as chief technology officer (CTO). Pfizer has seconded the appointment of Mr. Rathbun to CRIX International, an organization dedicated to providing a common infrastructure and suite of services to accelerate and streamline the interactions between members of the clinical research community. As CTO, Mr. Rathbun is responsible for overseeing and administering all aspects of technology and architecture for CRIX International, as well as making sure that the services delivered to industry by CRIX providers adhere to the standards established by CRIX to ensure open, scalable solutions. Chuck Swanson CISCRP Names Development Director The Center for Information and Study on Clinical Research Participation (CISCRP), a nonprofit organization focused on educating and informing the public about clinical research participation, has appointed Chuck Swanson director, development. In this role, Mr. Swanson works with CISCRP’s staff and board to build a comprehensive development program with clear priorities and accountabilities for fundraising and donor acquisition. Mr. Swanson was previously VP, business development, for Firecrest Clinical. Agency POOL Mike Bosniak Dan D’Alesio GSW Expands Newtown Staff Healthcare advertising agency GSW Worldwide, an inVentiv Health company, has announced two appointments to its staff. Mike Bosniak has joined as senior copywriter, from the same position at Kanter International. He received a bachelor’s degree from Temple University. Dan D’Alesio has been named associate creative director. Mr. D’Alesio previously was group creative supervisor at DraftFCB Healthcare. He holds a master’s degree from Rutgers University. Jill Clark Blue Diesel Expands Account Staff Jill Clark has been named senior account manager at interactive marketing agency Blue Diesel, an inVentiv Health company. Ms. Clark previously served as director of marketing for Glimcher. She holds a bachelor’s degree from Ohio University. Jared Davis Rafael Garza New Hires at Cadent Cadent Medical Communications, an inVentiv Health company, has announced two additions to its account team. Jared Davis has been named account executive. Mr. Davis was previously account coordinator for ProEd Communications. He holds a bachelor’s degree from Kent State University. Rafael Garza joins Cadent as VP, account services. Mr. Garza most recently served in a marketing position for Genentech. He earned a bachelor’s degree from Stanford University. Camela Morrissey New President at Dorland Global Public Relations Camela Morrissey has joined Dorland Global Public Relations (DGPR), a business unit of Dorland Global, as president, with responsibility for overseeing the PR business in the agency’s Philadelphia, San Francisco, and New York offices. Ms. Morrissey replaces Nancy Bacher Long, who remains with DGPR in a consultancy role. Ms. Morrissey has more than 20 years of experience in public relations, marketing, and communications management. Most recently, she served as VP, public affairs, marketing, and patient satisfaction, with New York Hospital Queens, part of the New York-Presbyterian Healthcare System. Service POOL Dr. Stephen Picataggio Verdezyne Selects Scientific Chief Metabolic engineering expert Stephen Picataggio, Ph.D., has joined Verdezyne as chief scientific officer. Verdezyne, formerly known as Coda Genomics, is a privately held synthetic biology company focused on enabling the creation of novel genes, proteins, and organisms. Dr. Picataggio has 30 years of experience in the metabolic engineering of industrial microorganisms and the development of fermentation processes for the production of fuels and chemicals, most recently as VP of metabolic engineering at Synthetic Genomics. He graduated magna cum laude with a B.S. in bacteriology and public health from Wagner College, and received his Ph.D. in microbiology from Rutgers University. Technology POOL Robert Barr Dr. Michelle Dockhorn Nextrials Expands Executive Staff Nextrials, a provider of clinical research software and services, has added two executives to its leadership team. Robert Barr has been appointed chief technology officer. Mr. Barr was previously VP of software engineering for ClinPhone. He holds a degree in mathematics and computer science from Southern Utah University. Michelle Dockhorn, Ph.D., has joined Nextrials as VP of global sales and marketing. In this newly created position, Dr. Dockhorn directs Nextrials’ new business initiatives and communications strategy. She was most recently VP of global sales and marketing at Focus Bio-Inova. Dr. Dockhorn received an MBA from the University of North Carolina and a Ph.D. in neurobiology from the University of Connecticut. Lex Jansen Octagon Research Appoints CDISC Consultant Octagon Research Solutions, a provider of software and services to the life-sciences industry, has named Lex Jansen senior consultant, clinical data strategies. In this role, Mr. Jansen offers guidance to pharmaceutical and biotechnology companies on the use of data integration technologies and best practices to convert electronic clinical data into a format compliant with CDISC. Most recently, he served as senior director, clinical information systems, at Take Solutions.

Posted in:

Post a Comment

You must be logged in to post a Comment.